Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines (Q40095116)

17 September 2017

Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines (English)

1 reference

17 September 2017

Holly E Hollingshead

1

1 reference

17 September 2017

Renee L Killins

2

1 reference

17 September 2017

Michael G Borland

3

1 reference

17 September 2017

Elizabeth E Girroir

4

1 reference

17 September 2017

Andrew N Billin

5

1 reference

17 September 2017

Timothy M Willson

6

1 reference

17 September 2017

Arun K Sharma

7

1 reference

17 September 2017

Shantu Amin

8

1 reference

17 September 2017

Frank J Gonzalez

9

1 reference

17 September 2017

Jeffrey M Peters

10

1 reference

17 September 2017

language of work or name

English

0 references

publication date

11 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

28

1 reference

17 September 2017

12

1 reference

17 September 2017

2641-2649

1 reference

Activation of PPARdelta alters lipid metabolism in db/db mice.

17 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Cross-talk between peroxisome proliferator-activated receptor delta and cytosolic phospholipase A(2)alpha/cyclooxygenase-2/prostaglandin E(2) signaling pathways in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARbeta/delta selectively induces differentiation and inhibits cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (PPARdelta) stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Effects of di(2-ethylhexyl) phthalate, a widely used peroxisome proliferator and plasticizer, on cell growth in the human keratinocyte cell line NCTC 2544.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

A Short and Efficient Synthesis of the Pharmacological Research Tool GW501516 for the Peroxisome Proliferator-Activated Receptor δ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARdelta regulates glucose metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARdelta is a very low-density lipoprotein sensor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

Inflammatory mediators and nuclear receptor signaling in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM183

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGM183

1 reference

17 September 2017

1 reference